Condition
Dysplastic Nevus Syndrome
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT00040352Recruiting
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
NCT04688749Terminated
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage
NCT04353050Not ApplicableUnknown
Atypical MOLes and Melanoma Early Detection Study (MoleMed)
NCT00346502Phase 1WithdrawnPrimary
Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)
Showing all 4 trials